Investigators from ongoing CBD oil studies at the University of Alabama at Birmingham (UAB) and Children's of Alabama are releasing their preliminary findings from the studies they launched in April of 2015. An abstract of the early results from the study reveal that of the first 51 subjects who enrolled in the studies, 50% responded to the CBD oil therapy with sustained improvement in seizure control over a six-month period. Those who responded positively experienced a reduction in seizures by 32-45%, depending on the dose. Two of the patients became completely seizure free, but nine patients dropped out of the study to a lack of efficacy or negative side effects.
While it's still too early to say, investigators are positive about the preliminary findings. Principal investigator and professor in the Department of Neurology Jerzy Szaflarski, M.D., Ph.D., says, "The studies are ongoing and we have a lot more to learn; but these preliminary findings are encouraging... Among our goals was to determine the safety of CBD oil therapy, and it appears that, in many cases, patients tolerate the oil quite well. The evidence of seizure reductions gives us hope that, the more we learn about CBD oil, the better we will be able to tailor this therapy to proved relief for those with severe epilepsy."
We look forward to learning about the final results when the study is complete. This information has been provided by UAB News and approved by our Chief Medical Officer.